Penserra Capital Management LLC Astrazeneca PLC Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
A detailed history of Penserra Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Penserra Capital Management LLC holds 3,126 shares of AZN stock, worth $217,538. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,126
Previous 30,843
89.86%
Holding current value
$217,538
Previous $2.41 Million
89.9%
% of portfolio
0.01%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,342Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.38 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.92 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.59 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.56 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.33 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...